Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases

Pharmacological Research

Volumn 121, Issue , 2017, Pages 129-137

  Meldolesi, Jacopo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; Intra and extracellular peptides; Neurodegeneration disease diagnosis; Neurodegeneration disease therapy; Neurotrophin receptors; p75NTR; p75NTR inhibitors; Receptor complexes; Trk; Trk stimulatory drugs

Indexed keywords

7,8 DIHYDROXYFLAVONE; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CEREBROLYSIN; LEVODOPA; LINGO 1 RECEPTOR; MEMANTINE; MICRORNA; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; NOGO 66 RECEPTOR; PROTEIN TYROSINE KINASE A; SORTILIN; UNCLASSIFIED DRUG; ZONISAMIDE; NERVE GROWTH FACTOR RECEPTOR;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; DEGENERATIVE DISEASE; EXERCISE; HUMAN; HUNTINGTON CHOREA; NERVE CELL PLASTICITY; NERVE FIBER DEGENERATION; NERVE REGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DEVELOPMENT; METABOLISM; MOLECULAR LIBRARY; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHARMACOLOGY; THERAPEUTIC USE;

ANIMALS; DRUG DISCOVERY; HUMANS; MOLECULAR TARGETED THERAPY; NEURODEGENERATIVE DISEASES; RECEPTORS, NERVE GROWTH FACTOR; SMALL MOLECULE LIBRARIES;

EID: 85019106466     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2017.04.024     Document Type: Review

References (109)

1. NTR trimers: implications for re ceptor stoichiometry and activation. J. Neurosci. 35 (2015), 11911–11920.
2. [2] Araki, T., et al. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area. Int. J. Geriatr. Psychiatry 29 (2014), 881–889.
3. [3] Ardini, E., et al. The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TrkA kinase inhibition. Mol. Oncol. 8 (2014), 1495–1507.
4. NTR and its ligand proNGF activate paracrine mechanisms etiological to the vascular, inflammatory and neurodegenerative pathologies in diabetic retinopathy. J. Neurosci. 36 (2016), 8826–8841.
5. NTR mediates Huntington's disease-associated synaptic and memory dysfunction. J. Clin. Invest. 124 (2014), 4411–4428.
6. [6] Castello, N.A., Nguyen, M.H., Tran, J.D., Cheng, D., Green, K.N., LaFerla, F.M., 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer's disease-like neuronal loss. PLoS One, 9, 2014, e91453.
7. NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J. Cell Sci. 123 (2010), 2299–2307.
8. [8] Chao, M.V., Rajagopal, R., Lee, F.S., Neurotrophin signaling in health and disease. Clin. Sci. (Lond.) 110 (2006), 167–173.
9. [9] Chen, J.T., et al. Presynaptic GABAergic inhibition regulated by BDNF contributes to neuropathic pain induction. Nat. Commun., 5, 2014, 5331.
10. [10] Chen, J.Y., Lin, J.R., Cimprich, K.A., Meyer, T., A two-dimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol. Cell 45 (2012), 196–209.
11. [11] Chopin, V., Lagadec, C., Toillon, R.A., Le Bourhis, X., Neurotrophin signaling in cancer stem cells. Cell Mol. Life Sci. 73 (2016), 1859–1870.
12. [12] Colombo, F., Racchetti, G., Meldolesi, J., News about two steps of TrkA receptor function: trans-activation by L1CAM and neurite outgrowth sustained by enlargeosome exocytosis. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 16943–16948.
13. [13] Croucher, J.L., et al. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. Cancer Chemother. Pharmacol. 75 (2015), 131–141.
14. [14] Demont, Y., et al. Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein. J. Biol. Chem. 287 (2012), 1923–1931.
15. [15] Ding, Y.X., et al. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice. Neurochem. Res. 36 (2011), 1759–1766.
16. [16] Dos Reis, R.C., Kopruszinski, C.M., Nones, C.F., Chichorro, J.G., Nerve growth factor induced facial heat hyperalgesia and plays a role in trigeminal neuropathic pain in rats. Behav. Pharmacol. 27 (2016), 528–535.
17. [17] Eskander, M.A., et al. Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms. J. Neurosci. 35 (2015), 8593–8603.
18. [18] Evans, S.F., et al. Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J. Biol. Chem. 286 (2011), 29556–29567.
19. [19] Fei, D., Krimm, R.E., Taste neurons consist of both a large TrkB-receptor-dependent and a small TrkB-receptor-independent subpopulation. PLoS One, 8, 2013, e83460.
20. NTR and sortilin. Mol. Biol. 396 (2010), 967–984.
21. [21] Feng, N., et al. Constitutive BDNF-TrkB signaling is required for normal cardiac contraction and relaxation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 1880–1885.
22. [22] Foreman, R.D., Garrett, K.M., Blair, R.W., Mechanisms of cardiac pain. Compr. Physiol. 5 (2015), 929–960.
23. [23] Forsyth, P.A., et al. p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J. Biol. Chem. 289 (2014), 8067–8085.
24. [24] Gauthier, S., Proaño, J.V., Jia, J., Froelich, L., Vester, J.C., Doppler, E., Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Dement. Geriatr. Cogn. Disord. 39 (2015), 332–347.
25. [25] Genevois, A.L., et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 3017–3022.
26. NTR control excitability and persistent firing of cortical pyramidal neurons. J. Neurosci. 35 (2015), 9741–9753.
27. [27] Green, C.R., Corsi-Travali, S., Neumeister, A., The role of BDNF-TrkB signaling in the pathogenesis of PTSD. J. Depress. Anxiety(S4), 2013.
28. [28] Gui, Y., Liu, H., Zhang, L., Lv, W., Hu, X., Altered microRNA profiles in cerebrospinal fluid exosomes in Parkinson's disease and Alzheimer's disease. Oncotarget 6 (2015), 37043–37053.
29. [29] Guo, W., Ji, Y., Wang, S., Sun, Y., Lu, B., Neuronal activity alters BDNF-TrkB signaling kinetics and downstream functions. J. Cell Sci. 127 (2014), 2249–2260.
30. [30] Heldt, S.A., Zimmermann, K., Parker, K., Gaval, M., Weinshenker, D., Ressler, K.J., BDNF deletion or TrkB impairment in amygdala inhibits both appetitive and aversive learning. J. Neurosci. 34 (2014), 2444–2450.
31. NTR in sympathetic neurons. Mol. Cell. Neurosci. 32 (2006), 387–402.
32. NTR complex is responsible for β-amyloid-induced cortical neural death. Cell. Death. Dis., 4, 2013, e579.
33. NTR in neuronal ischemic injury. J. Neurosci. 34 (2014), 3419–3428.
34. [34] Iyer, R., et al. Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model. Cancer Lett. 372 (2016), 179–186.
35. [35] Jeronimo-Santos, A., et al. Dysregulation of TrkB receptors and BDNF function in amyloid-β peptide is mediated by calpain. Cereb. Cortex 25 (2015), 3107–3121.
36. [36] Jiang, H., Huang, S., Li, X., Li, X., Zhang, Y., Chen, Z.Y., Tyrosine kinase B protects against coronary artery disease and promotes adult vasculature integrity by regulating Ets1-mediated VE-caderin expression. Atheroscler. Thromb. Vasc. Biol. 35 (2015), 580–588.
37. [37] Jiang, M., et al. Small-molecule TrkB receptor agonists improve motor function and extends survival in a mouse model of Huntington's disease. Hum. Mol. Genet. 22 (2013), 2462–2470.
38. NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker. Transl. Psychiatry, 5, 2015, e650.
39. [39] Joo, W., Hippenmeyer, S., Luo, L., Neurodevelopment. Dendrite morphogenesis depends on relative levels of NT3/TrkC signaling. Science 346:2014 (2014), 626–629.
40. [40] Kudlubowska, J., Malaguarnera, L., Wąż, P., Zorena, K., Neurodegeneration and neuroinflamation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr. Neuropharmacol. 14 (2016), 831–839.
41. [41] Le Moan, N., Houslay, D.M., Christian, F., Houslay, M.D., Akassoglou, K., Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. Mol. Cell 44 (2011), 476–490.
42. [42] Leal, G., et al. Regulation of hippocampal synaptic plasticity by BDNF. Brain Res. 1621 (2015), 82–101.
43. [43] Li, Z., Zhang, Y., Tong, Y., Tong, J., Thiele, C.L., Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo. Cancer Biol. Ther. 16 (2015), 477–483.
44. [44] Lim, J.Y., Reighard, C.P., Crowther, D.C., The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with Aβ. Hum. Mol. Genet. 24 (2015), 3929–3938.
45. [45] Liu, X.H., et al. Blocking GSK3β-mediated dynamin phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease. Neurobiol. Dis. 74 (2015), 377–391.
46. [46] Longart, M., et al. Sciatic nerve conditioned medium depleted of pro-NGF modulates sodium currents and neurite outgrowth in PC12 cells. Neuroscience 159 (2009), 550–558.
47. [47] Longo, F.M., Massa, S.M., Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat. Rev. Drug Discov. 12 (2013), 507–525.
48. [48] Lorentz, C.U., et al. Synpathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor. Exp. Neurol. 249 (2013), 111–119.
49. [49] Mariga, A., Zavadil, J., Ginsberg, S.D., Chao, M.V., Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Dev. Neurobiol. 75 (2015), 173–192.
50. [50] Matusica, D., et al. Inhibition of motor neuron death in vitro and in vivo by p75 neurotrophin receptor intracellular domain fragment. J. Cell Sci. 129 (2016), 517–530.
51. [51] Meeker, R.B., Poulton, W., Clary, G., Schriver, M., Longo, F.M., Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis. Exp. Neurol. 275:Pt. 1 (2016), 182–198.
52. [52] Mitchell, D.J., et al. Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. J. Neurosci. 32 (2012), 15495–15510.
53. [53] Mufson, E.J., et al. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J. Neuropathol. Exp. Neurol. 710 (2012), 1018–1029.
54. [54] Murphy, M., et al. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease. Neurobiol. Aging 36 (2015), 740–752.
55. NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration and cognitive deficits in A(PP(L/S) transgenic mice. J. Alzheimer's Dis. 42 (2014), 459–483.
56. [56] Nie, S., et al. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP-induced neurotoxicity in rodents. Neuropharmacology 99 (2015), 448–458.
57. [57] Nykjaer, A., Willnow, T.E., Sortilin: a receptor to regulate neuronal viability and function. Trends Neurosci. 35 (2012), 261–270.
58. [58] Odate, S., et al. Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary target cell of neuroendocrine carcinoma. Anticancer Res. 33 (2013), 3699–3703.
59. NTR receptor-mediated activation of RhoA signaling pathways. Cell. Death. Dis., 6, 2015, e1876.
60. [60] Panja, D., et al. Two stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling. Cell Rep. 9 (2014), 1430–1445.
61. [61] Parkhurst, C.N., Zampieri, N., Chao, M.V., Nuclear localization of the p75 neurotrophin receptor intracellular domain. J. Biol. Chem. 285 (2010), 5361–5368.
62. [62] Penzo, M.A., et al. The paraventricular thalamus controls a central amygdala fear circuit. Nature 519 (2015), 455–459.
63. [63] Philippidou, P., Valdez, G., Akmentin, W., Bowers, W.J., Federoff, H.J., Halegoua, S., Trk retrograde signaling requires persistent, Pincher-directed endosomes. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 852–857.
64. NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth. EMBO J. 28 (2009), 261–273.
65. [65] Plotkin, J.L., et al. Impaired TrkB receptor signaling underlies cortico-striatal dysfunction in Huntington's disease. Neuron 83 (2014), 178–188.
66. NTR signaling. Rare Dis., 2, 2014, e968482.
67. [67] Puehringer, D., et al. EGF trans-activation of Trk receptors regulates the migration of newborn cortical neurons. Nat. Neurosci. 16 (2013), 407–415.
68. [68] Qi, D., et al. HO-1 attenuates hippocampal neuron injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke. Brain Res. 1577 (2014), 69–76.
69. [69] Real, C.C., Ferreira, A.F., Chaves-Kirsten, G.P., Torrão, A.S., Pires, R.S., Britto, L.-R., BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease. Neuroscience 237 (2013), 118–129.
70. [70] Reichardt, L.F., Neurotrophin-regulated signaling pathways. Phylos. Trans. Soc. Lond. B Biol. Sci. 361 (2006), 1545–1654.
71. [71] Seo, J.H., et al. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer. Cancer Lett. 338 (2013), 271–281.
72. [72] Shepheard, S.R., Chataway, T., Schultz, D.W., Rush, R.A., Rogers, M.L., The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS One, 9, 2014, e87398.
73. [73] Shih, C.H., Chen, C.J., Chen, L., New function of the adaptor protein SH2B1 in brain-derived neurotrophic factor-induced neurite outgrowth. PLoS One, 8, 2013, e79619.
74. NTR interactions by small molecule inhibitors. Pharmacol. Res. 103 (2016), 292–299.
75. NTR in neurological disorders: a novel therapeutic target. Biomed. Pharmacother. 76 (2015), 17–23.
76. NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression. PLoS One, 9, 2014, e102136.
77. NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice. Hum. Mol. Genet. 25 (2016), 4920–4938.
78. [78] Sinkevicius, K.W., et al. Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 10299–10304.
79. [79] Sita, G., Hrelia, P., Tarozzi, A., Morroni, F.G., Isothiocyanates are promising compounds against oxydative stress, neuroinflamation and cell death that may benefit neurodegeneration in Parkinson's disease. Int. J. Mol. Sci., 17, 2016, E1454.
80. [80] Skeldal, S., et al. Mapping of the interaction between sortilin and the p75 neurotrophin receptor reveals a regulatory role for the sortilin intracellular domain in p75 neurotrophin receptor shedding and apoptosis. J. Biol. Chem. 287 (2012), 43798–43809.
81. [81] Song, E.J., Yoo, Y.S., Nerve growth factor-induced neurite outgrowth is potentiated by stabilization of TrkA receptors. BMB Rep. 44 (2011), 182–186.
82. [82] Taborsky, G.J., Mei, Q., Bornfeldt, K.E., Hackney, D.J., Mundinger, T.O., The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attack. Diabetes 63 (2014), 2369–2379.
83. [83] Todd, D., et al. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease. PLoS One, 9, 2014, e87923.
84. [84] Trigos, A.S., Longart, M., García, L., Castillo, C., Forsyth, P., Medina, R., ProNGF derived from rat sciatic nerves down-regulates neurite elongation and axon specification in PC12 cells. Front. Cell. Neurosci., 9, 2015, 364.
85. [85] Tripp, A., Oh, H., Guilloux, J.P., Martinowich, K., Lewis, D.A., Sibille, E., Brain-derived neurotrophic factor signaling and subgenual anterior cingulated cortex disfunction in major depressive disorder. Am. J. Psychiatry 169 (2012), 1194–1202.
86. [86] Ubhi, K., et al. Cerebrolysin modulates pro-nerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease. J. Neurosci. Res. 91 (2013), 167–177.
87. [87] Vaegter, C.B., et al. Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat. Neurosci. 14 (2011), 54–61.
88. [88] Vaishnavi, A., Le, A.T., Doebele, R.C., TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 5 (2015), 25–34.
89. [89] Verma, A., et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy?. Ophthalmic Res. 47 (2012), 202–207.
90. [90] Vilar, M., et al. Heterodimerization of p45-p75 modulates p75 signaling: structural basis and mechanism of action. PLoS Biol., 12, 2014, e1001918.
91. [91] Wang, L., Chang, X., She, L., Xu, D., Huang, W., Poo, M.M., Autocrine action of BDNF on dendrite development of adult-born hippocampal neurons. J. Neurosci. 35 (2015), 8384–8393.
92. NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP-PS1 transgenic mice. J. Neurochem. 138 (2016), 163–173.
93. [93] Xia, Y., et al. Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults. Int. J. Mol. Sci. 14 (2013), 14085–14104.
94. [94] Xiang, L., Ren, Y., Cai, H., Zhao, W., Song, Y., MicroRNA-132 aggravates epileptiform discharges via suppression of BDNF/TrkB signaling in cultured hippocampal neurons. Brain Res. 1622 (2015), 484–495.
95. [95] Yaar, M., et al. Aβ binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 277 (2002), 7720–7725.
96. [96] Yagi, H., et al. Zonisamide enhances neurite elongation of primary motor neurons and facilitates peripheral nerve regeneration In vitro and in a mouse model. PLoS One, 10, 2015, e0142786.
97. [97] Yan, Y., Eipper, B.A., Mains, R.E., Kalirin is required for BDNF-TrkB stimulated neurite outgrowth and branching. Neuropharmacology 107 (2016), 227–238.
98. [98] Yang, J., et al. proBDNF negatively regulates neuronal remodeling, synaptic transmission and synaptic plasticity in hippocampus. Cell Rep. 7 (2014), 796–806.
99. NTR ectodomain is a physiological neuroprotective molecule against amyloid-β toxicity in the brain of Alzheimer's disease. Mol. Psychiatry 20 (2015), 1301–1310.
100. [100] Zacharyan, R., Atshemyan, S., Gevorgyan, A., Boyajyan, A., Nerve growth factor and its receptor in schizophrenia. BBA Clin. 1 (2014), 24–29.
101. [101] Zhang, G., et al. In depth quantitative proteomic analysis of de novo protein synthesis induced by brain-derived neurotrophic factor. J. Proteome Res. 13 (2014), 5707–5714.
102. [102] Zhang, J., Wang, L.S., Ye, S.L., Luo, P., Wang, B.L., Blockage of tropomyosin receptor kinase A (TrkA) enhances chemo-sensitivity in breast cancer cells and inhibits metastasis in vivo. Int. J. Clin. Exp. Med. 8 (2015), 634–641.
103. [103] Zhang, W., et al. TrkC expression predicts favorable clinical outcome in invasive ductal carcinoma of breast independent of NT3 expression. Am. J. Cancer Res. 4 (2014), 611–623.
104. [104] Zhao, L., Yeh, M.L., Levine, E.S., Role for endogenous BDNF in endocannabinoid-mediated long-term depression at neocortical inhibitory synapses. eNeuro 2 (2015), e0029–14.
105. [105] Zheng, C., Geetha, T., Gearing, M., Babu, R., Amyloid β-abrogated TrkA ubiquitination in PC12 cells analogous to Alzheimer's disease. J. Neurochem. 133 (2015), 919–925.
106. [106] Zhu, G., Li, J., He, L., Wang, X., Hong, X., MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Brit. J. Pharmacol. 172 (2015), 2354–2368.
107. [107] Zhu, Y., et al. Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression. J. Clin. Invest. 123 (2013), 2935–2947.
108. [108] Zonta, B., Minichiello, L., Synaptic membrane rafts: traffic lights for local neurotrophin signaling?. Front. Synaptic Neurosci., 5, 2013, 9.
109. NTR specifies axons during development and adult neurogenesis. Cell Rep. 7 (2014), 138–152.